Digestive & Intestinal Remedies (Pharmacies) - Turkey

  • Turkey
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$12.91m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.34%, resulting in a market volume of US$14.49m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.15 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Turkey has been experiencing significant growth in recent years.

Customer preferences:
Customers in Turkey are increasingly seeking digestive and intestinal remedies to address common gastrointestinal issues such as indigestion, heartburn, and constipation. This is partly due to changes in lifestyle and dietary habits, including the consumption of processed foods and a lack of physical activity. As a result, there is a growing demand for over-the-counter remedies that can provide quick relief and improve digestive health.

Trends in the market:
One major trend in the Digestive & Intestinal Remedies market in Turkey is the shift towards natural and herbal remedies. Consumers are becoming more conscious about the ingredients in the products they use and are looking for natural alternatives to traditional pharmaceutical remedies. This trend is driven by a desire for safer and more sustainable options, as well as a growing interest in holistic approaches to health and wellness. Another trend is the increasing availability and accessibility of digestive and intestinal remedies in pharmacies across the country. Pharmacies are expanding their product offerings to cater to the growing demand, and customers can now find a wide range of remedies for various digestive issues. This trend is also supported by the growing number of pharmacies in Turkey, as well as the increasing presence of chain pharmacies that have a larger selection of products.

Local special circumstances:
Turkey has a relatively high prevalence of gastrointestinal issues compared to other countries. This can be attributed to factors such as a high intake of spicy and fatty foods, irregular eating patterns, and stress. As a result, there is a greater need for digestive and intestinal remedies in the market. Additionally, the Turkish population is aging, which can contribute to an increased demand for these products as older individuals are more likely to experience digestive issues.

Underlying macroeconomic factors:
The growing Digestive & Intestinal Remedies market in Turkey can also be attributed to several underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and improved access to healthcare. As a result, consumers are more willing to spend on healthcare products, including digestive and intestinal remedies. Furthermore, the government has been implementing healthcare reforms to improve access to healthcare services, which has also contributed to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Turkey is experiencing growth due to customer preferences for quick relief and improved digestive health. The market is also influenced by trends towards natural and herbal remedies, as well as the increasing availability of these products in pharmacies. Local special circumstances, such as the high prevalence of gastrointestinal issues and an aging population, further contribute to the growth of the market. Underlying macroeconomic factors, including economic growth and healthcare reforms, also play a role in driving the market forward.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)